PEOPLE - Calypte Biomedical makes appointment:
This article was originally published in Clinica
Nancy Katz has been appointed president, chief operating officer and board director of Calypte Biomedical. Ms Katz was most recently with Johnson and Johnson's diabetes testing division, Lifescan. In addition, David Collins becomes CEO, succeeding Bill Boeger who will continue as chairman. Calypte is a US manufacturer of urine-based HIV-1 tests.